The resultant nanoparticles (RGD-HBc/QGd) possess excellent potential as NIR fluorescent and magnetic resonance imaging contrast agents for hepatic fibrosis in vivo if they are enclosed in a quercetin-gadolinium complex and/or labelled with the NIR fluorescent probes (Cy5.5). Here, KRT88P is linked to Hepatic fibrosis.